Studying the use of patients' reprogrammed T-cells to attack cancer as an alternative to more chemo.

Originally published by Meg Wingerter, The Denver Post, on March 14, 2024

         Credit: Unsplash/CC0 Public Domain

A process of taking patients' own cells and reprogramming them to fight cancer has been a last-ditch option for blood cancer patients when nothing else worked, but a new study underway in Aurora is trying to determine whether more patients could benefit from trying the procedure sooner.

Chimeric antigen receptor T cell therapy, known as CAR-T, is a type of immunotherapy that involves taking cells from the patient's body and altering them to attack cancerous cells that have specific proteins on their surfaces. The patient then gets the altered cells by infusion.

A study at University of Colorado's Gates Institute on the Anschutz Medical Campus is looking at CAR-T in adult patients with , a cancer of the blood and , whose first round of chemotherapy either failed or gave a disappointing response that suggests it won't work for long, executive director Dr. Terry Fry said.

This specific study is looking for safety and will have preliminary results next year. Assuming it doesn't find any problems, a larger study would test if patients do better when receiving CAR-T rather than another round of chemotherapy, Fry said.

When a is new and carries unknown risks, typically the first patients who receive it are those who are out of other options, Fry said. If it works well and doesn't cause unacceptable side effects for patients whose cancer resisted treatment, then researchers start looking into whether offering it earlier could make sense, he said.

"When we see something is successful, we forget that someone had to be that first patient" and take risks, he said.

Generally, people with the type of leukemia CU is studying have two options: chemotherapy or a , both of which can be grueling, Fry said. The advantage of CAR-T, when it works, is that the patient only has to take it once, he said.

"It can be advantageous to take a single treatment, get on with their life and have done with it," he said.

Read more

Comments

Post a Comment

Popular posts from this blog

Research finds resin that destroys coronavirus on plastic surfaces

Image
O riginally published by University of Jyväskylä, on January 30, 2024 Studying the impact of rosin-functionalized plastic and standard LDPE on the structure of HCoV-OC43 using (A) TEM and (B) AFM in liquid. The scale bar corresponds to 100 nm and 1 µm in the TEM and AFM images, respectively. In panel B, the blue circle highlights a doughnut-shaped virus. (C) The histogram derived from the AFM images illustrates the average size distribution of the height of individual viruses after being flushed from their respective surfaces. Credit: Microbiology Spectrum (2024). DOI: 10.1128/spectrum.03008-23 Researchers at the University of Jyväskylä, Finland , are currently developing anti-viral surfaces to decrease the spread of infectious diseases. A recent study published in Microbiology Spectrum found that a resin ingredient is effective against coronaviruses and strongly decreases their infectivity on plastic surfaces. Viruses may persist on solid surfaces for long periods, which ma
Read more

Engineered Rabies Virus Illuminates Neural Circuitry

Image
Originally published by Hannah Thomasy, PhD, for the Scientist on June 14, 2024 Scientists turned a deadly virus into a crucial tool for understanding the wiring of the brain.   Rabies labeling helps scientists identify neurons in the primary visual cortex that connect to two different higher visual brain regions. Marina Garrett  In 1906 , pathologist Camillo Golgi and neuroscientist Santiago Ramón y Cajal won the Nobel Prize for their work on the structure of the nervous system . More than a century later, the puzzle of nervous system organization —the intricately tangled mess that results from each neuron’s connections to thousands of others— remains incomplete . Yet, fully developing scientific understanding of these connections is crucial , said Edward Callaway , a systems neurobiologist at the Salk Institute . “If you don’t have some knowledge about how the different parts are interacting , there’s no way to generate a hypothesis about how they’re working together .”  N
Read more

Study discovers cellular activity that hints recycling is in our DNA

Image
Originally published by by Rose Miyatsu, University of California - Santa Cruz , on May 11, 2024 Shown is the splicing pathway. The pre-messenger RNA (pre-mRNA) has exons (blue) and introns (pink). The spliceosome (not shown) was known to catalyze two chemical reactions (black arrows) in a two-step process (green arrows labeled 1 and 2) that splice the exons together and removes the intron as a lariat. This study demonstrates that after splicing is finished, the spliceosome is still active and can convert the lariat intron into a circle using a third reaction (green arrow 3) marked by an asterix. Credit: Manuel Ares, UC Santa Cruz Although you may not appreciate them, or have even heard of them, throughout your body , countless microscopic machines called spliceosomes are hard at work . As you sit and read, they are faithfully and rapidly putting back together the broken information in your genes by removing sequences called " introns " so that your messenger RNAs can
Read more